Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

NCT06335069 ·Status: RECRUITING ·Phase: PHASE2

PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer

NCT00236275 ·Status: COMPLETED ·Phase: PHASE3

Positron Emission Tomography in Patients With Breast Cancer

NCT00001385 ·Status: COMPLETED

PET-CT in Lymphoma Among the Eldery

NCT07259941 ·Status: NOT_YET_RECRUITING

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

NCT00201942 ·Status: COMPLETED ·Phase: PHASE3

Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

NCT04464590 ·Status: COMPLETED

FDG PET-CT in Advanced Breast Cancer

NCT07173868 ·Status: RECRUITING

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

NCT02317393 ·Status: COMPLETED ·Phase: PHASE2

FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer

NCT06877949 ·Status: RECRUITING ·Phase: NA

FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer

NCT01432002 ·Status: UNKNOWN

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

NCT04758416 ·Status: UNKNOWN

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

NCT04824014 ·Status: RECRUITING ·Phase: PHASE2

18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma

NCT03121456 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer

NCT01621529 ·Status: COMPLETED

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

NCT02751710 ·Status: COMPLETED ·Phase: NA

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study

NCT00686465 ·Status: COMPLETED ·Phase: NA

Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy

NCT07012707 ·Status: NOT_YET_RECRUITING

Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast

NCT01659645 ·Status: COMPLETED ·Phase: EARLY_PHASE1

FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

NCT03726931 ·Status: COMPLETED ·Phase: NA

Early Versus Late FDG-PET/CT in Bladder Cancer

NCT03065725 ·Status: COMPLETED

Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis

NCT05762172 ·Status: COMPLETED ·Phase: NA

Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers

NCT02966574 ·Status: UNKNOWN ·Phase: NA

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

NCT02386709 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

NCT06557148 ·Status: RECRUITING

The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma

NCT00498667 ·Status: WITHDRAWN